Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195988820> ?p ?o ?g. }
- W3195988820 endingPage "1278" @default.
- W3195988820 startingPage "1278" @default.
- W3195988820 abstract "The peptide hormone Angiotensin (1-7), Ang (1-7) or (Asp-Arg-Val-Tyr-Ile-His-Pro), is an essential component of the renin-angiotensin system (RAS) peripherally and is an agonist of the Mas receptor centrally. Activation of this receptor in the CNS stimulates various biological activities that make the Ang (1-7)/MAS axis a novel therapeutic approach for the treatment of many diseases. The related O-linked glycopeptide, Asp-Arg-Val-Tyr-Ile-His-Ser-(O-β-D-Glc)-amide (PNA5), is a biousian revision of the native peptide hormone Ang (1-7) and shows enhanced stability in vivo and greater levels of brain penetration. We have synthesized the native Ang (1-7) peptide and the glycopeptide, PNA5, and have formulated them for targeted respiratory delivery as inhalable dry powders. Solid phase peptide synthesis (SPPS) successfully produced Ang (1-7) and PNA5. Measurements of solubility and lipophilicity of raw Ang (1-7) and raw PNA5 using experimental and computational approaches confirmed that both the peptide and glycopeptide have high-water solubility and are amphipathic. Advanced organic solution spray drying was used to engineer the particles and produce spray-dried powders (SD) of both the peptide and the glycopeptide, as well as co-spray-dried powders (co-SD) with the non-reducing sugar and pharmaceutical excipient, trehalose. The native peptide, glycopeptide, SD, and co-SD powders were comprehensively characterized, and exhibited distinct glass transitions (Tg) consistent with the amorphous glassy state formation with Tgs that are compatible with use in vivo. The homogeneous particles displayed small sizes in the nanometer size range and low residual water content in the solid-state. Excellent aerosol dispersion performance with a human DPI device was demonstrated. In vitro human cell viability assays showed that Ang (1-7) and PNA5 are biocompatible and safe for different human respiratory and brain cells." @default.
- W3195988820 created "2021-08-30" @default.
- W3195988820 creator A5004674693 @default.
- W3195988820 creator A5007270786 @default.
- W3195988820 creator A5014414724 @default.
- W3195988820 creator A5028103234 @default.
- W3195988820 creator A5038869150 @default.
- W3195988820 creator A5039937221 @default.
- W3195988820 date "2021-08-17" @default.
- W3195988820 modified "2023-10-16" @default.
- W3195988820 title "Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1—7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers" @default.
- W3195988820 cites W1522161842 @default.
- W3195988820 cites W1838176546 @default.
- W3195988820 cites W1974905310 @default.
- W3195988820 cites W1978693401 @default.
- W3195988820 cites W1996888759 @default.
- W3195988820 cites W1997071885 @default.
- W3195988820 cites W2020147090 @default.
- W3195988820 cites W2027424876 @default.
- W3195988820 cites W2027894892 @default.
- W3195988820 cites W2028690412 @default.
- W3195988820 cites W2029846933 @default.
- W3195988820 cites W2047152672 @default.
- W3195988820 cites W2052131862 @default.
- W3195988820 cites W2055973748 @default.
- W3195988820 cites W2060125421 @default.
- W3195988820 cites W2063863944 @default.
- W3195988820 cites W2065204794 @default.
- W3195988820 cites W2066828907 @default.
- W3195988820 cites W2072022722 @default.
- W3195988820 cites W2072416521 @default.
- W3195988820 cites W2077064436 @default.
- W3195988820 cites W2078376550 @default.
- W3195988820 cites W2083336327 @default.
- W3195988820 cites W2085051997 @default.
- W3195988820 cites W2108264490 @default.
- W3195988820 cites W2112553603 @default.
- W3195988820 cites W2121444977 @default.
- W3195988820 cites W2163426424 @default.
- W3195988820 cites W2170708063 @default.
- W3195988820 cites W2259383330 @default.
- W3195988820 cites W2279452326 @default.
- W3195988820 cites W2401152555 @default.
- W3195988820 cites W2497451167 @default.
- W3195988820 cites W2508278033 @default.
- W3195988820 cites W2516859479 @default.
- W3195988820 cites W2523920371 @default.
- W3195988820 cites W2548133807 @default.
- W3195988820 cites W2588448590 @default.
- W3195988820 cites W2589655875 @default.
- W3195988820 cites W2740357483 @default.
- W3195988820 cites W2778624434 @default.
- W3195988820 cites W2780715796 @default.
- W3195988820 cites W2794251447 @default.
- W3195988820 cites W2904447805 @default.
- W3195988820 cites W2912002070 @default.
- W3195988820 cites W2914468039 @default.
- W3195988820 cites W2946564651 @default.
- W3195988820 cites W3000629417 @default.
- W3195988820 cites W3007829240 @default.
- W3195988820 cites W3013729028 @default.
- W3195988820 cites W3014571869 @default.
- W3195988820 cites W3019582583 @default.
- W3195988820 cites W3042018556 @default.
- W3195988820 cites W3052397347 @default.
- W3195988820 cites W3098811554 @default.
- W3195988820 cites W3117695877 @default.
- W3195988820 cites W3127067936 @default.
- W3195988820 cites W3127297964 @default.
- W3195988820 cites W3136886705 @default.
- W3195988820 cites W3169725681 @default.
- W3195988820 cites W3178711868 @default.
- W3195988820 cites W4254689880 @default.
- W3195988820 doi "https://doi.org/10.3390/pharmaceutics13081278" @default.
- W3195988820 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8398878" @default.
- W3195988820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34452239" @default.
- W3195988820 hasPublicationYear "2021" @default.
- W3195988820 type Work @default.
- W3195988820 sameAs 3195988820 @default.
- W3195988820 citedByCount "8" @default.
- W3195988820 countsByYear W31959888202021 @default.
- W3195988820 countsByYear W31959888202022 @default.
- W3195988820 crossrefType "journal-article" @default.
- W3195988820 hasAuthorship W3195988820A5004674693 @default.
- W3195988820 hasAuthorship W3195988820A5007270786 @default.
- W3195988820 hasAuthorship W3195988820A5014414724 @default.
- W3195988820 hasAuthorship W3195988820A5028103234 @default.
- W3195988820 hasAuthorship W3195988820A5038869150 @default.
- W3195988820 hasAuthorship W3195988820A5039937221 @default.
- W3195988820 hasBestOaLocation W31959888201 @default.
- W3195988820 hasConcept C137610392 @default.
- W3195988820 hasConcept C155574463 @default.
- W3195988820 hasConcept C167392928 @default.
- W3195988820 hasConcept C170493617 @default.
- W3195988820 hasConcept C178790620 @default.
- W3195988820 hasConcept C185592680 @default.
- W3195988820 hasConcept C2777239854 @default.
- W3195988820 hasConcept C2778452849 @default.